Resverlogix Corp

(RVXCF)

By |

Profile

Resverlogix Corp clinical stage biotechnology company. Resverlogix is developing an advanced epigenetic drug called apabetalone for the treatment of patients with cardiovascular disease, diabetes mellitus, chronic kidney disease, peripheral artery disease, orphan diseases, and neurodegenerative diseases.

Contact Information

Website: www.resverlogix.com
Email: sarah@resverlogix.com
Main Phone: +1 403 254-9252
Address: 4820 Richard Road SW
Address 2: Suite 300
State: AB
City / Town: Calgary
Country: CAN
Postal Code: T3E 6L1

Issuer Information

Exchange: OTO
CEO: Donald McCaffrey
Employees: 30
NAICS: Biological Product (except Diagnostic) Manufacturing(325414)


Gathering Data... Please wait

Profile

Resverlogix Corp clinical stage biotechnology company. Resverlogix is developing an advanced epigenetic drug called apabetalone for the treatment of patients with cardiovascular disease, diabetes mellitus, chronic kidney disease, peripheral artery disease, orphan diseases, and neurodegenerative diseases.

Contact Information

Website: www.resverlogix.com
Email: sarah@resverlogix.com
Main Phone: +1 403 254-9252
Address: 4820 Richard Road SW
Address 2: Suite 300
State: AB
City / Town: Calgary
Country: CAN
Postal Code: T3E 6L1

Issuer Information

Exchange: OTO
CEO: Donald McCaffrey
Employees: 30
NAICS: Biological Product (except Diagnostic) Manufacturing(325414)
$ 2.40 $ -0.04 (-1.64%)
Last Price 2.40 Change $ -0.04 Change % -1.64 Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open 2.55 High 2.55 Low 2.40 Prev Close 2.44
Last Trade Volume 3,900 52 Wk Hi 3.45 52 Wk Low 0.84
Market Cap 463.3 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 193,049,999.00 EPS (TTM) -0.10 PE Ratio N/A Exchange OTCPK